Chronic liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are currently receiving treatment for chronic liver disease at our hospital Patients who understand the contents of this study and have given written consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who wish to be excluded from the study If the principal investigator determines that the patient is ineligible to participate in the study for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical impact of UBXD8 gene polymorphism on the pathogenesis of chronic liver diseases | — |
Countries
Japan
Contacts
Nagoya University Hospital Department of Gastroenterology and Hepatology